1. Retinoid-induced vasculitis

   Newsletter Article 06 February 2013 Pages: 2 - 2

2. Adverse metabolic effects of antihypertensive therapy

   Newsletter Article 06 February 2013 Pages: 2 - 3

3. Questionable therapeutic benefit with hydroxyquinolines

   Newsletter Article 06 February 2013 Pages: 3 - 3

4. Alcohol overdose

   Newsletter Article 06 February 2013 Pages: 4 - 4

5. Alcohol poisoning

   Newsletter Article 06 February 2013 Pages: 4 - 4

6. Antidepressants, tricyclic interaction

   Newsletter Article 06 February 2013 Pages: 4 - 4

7. Antihypertensives

   Newsletter Article 06 February 2013 Pages: 4 - 4

8. Bezafibrate/exifone

   Newsletter Article 06 February 2013 Pages: 4 - 4

9. Bleomycin/cisplatin/vincristine

   Newsletter Article 06 February 2013 Pages: 4 - 5

10. Cathartic

    Newsletter Article 06 February 2013 Pages: 5 - 5

11. Cathartic overdose

    Newsletter Article 06 February 2013 Pages: 5 - 5

12. Chloramphenicol

    Newsletter Article 06 February 2013 Pages: 5 - 5

13. Chloroquine

    Newsletter Article 06 February 2013 Pages: 5 - 5

14. Cisplatin see Bleomycin/cisplatin/vincristine

    Newsletter Article 06 February 2013 Pages: 5 - 5

15. Cocaine

    Newsletter Article 06 February 2013 Pages: 5 - 5

16. Cocaine withdrawal

    Newsletter Article 06 February 2013 Pages: 5 - 5

17. Cotrimoxazole

    Newsletter Article 06 February 2013 Pages: 5 - 6

18. Cyclosporin

    Newsletter Article 06 February 2013 Pages: 6 - 6

19. Encainide withdrawal

    Newsletter Article 06 February 2013 Pages: 6 - 6

20. Epirubicin see Doxorubicin/epirubicin

    Newsletter Article 06 February 2013 Pages: 6 - 6

21. Exifone

    Newsletter Article 06 February 2013 Pages: 6 - 7

22. Exifone see Bezafibrate/exifone

    Newsletter Article 06 February 2013 Pages: 7 - 7

23. Fluoxetine see Antidepressants, tricyclic interaction

    Newsletter Article 06 February 2013 Pages: 7 - 7

24. Heparin

    Newsletter Article 06 February 2013 Pages: 7 - 7

25. Imipenem

    Newsletter Article 06 February 2013 Pages: 7 - 7

26. Indomethacin

    Newsletter Article 06 February 2013 Pages: 7 - 7

27. Interferon beta see Interleukin 2/interferon beta

    Newsletter Article 06 February 2013 Pages: 7 - 7

28. Interleukin 2/interferon beta

    Newsletter Article 06 February 2013 Pages: 7 - 7

29. Methotrexate

    Newsletter Article 06 February 2013 Pages: 7 - 7

30. Minocycline

    Newsletter Article 06 February 2013 Pages: 8 - 8

31. Minoxidil

    Newsletter Article 06 February 2013 Pages: 8 - 8

32. OKT 3

    Newsletter Article 06 February 2013 Pages: 8 - 8

33. Rifampicin

    Newsletter Article 06 February 2013 Pages: 8 - 8

34. Sulfalene see Trimethoprim +; sulfalene overdose

    Newsletter Article 06 February 2013 Pages: 8 - 8

35. Sulfasalazine

    Newsletter Article 06 February 2013 Pages: 8 - 8

36. Trimethoprim +; sulfalene overdose

    Newsletter Article 06 February 2013 Pages: 8 - 8

37. Vaccine, poliovirus live oral

    Newsletter Article 06 February 2013 Pages: 8 - 8

38. Vincristine see Bleomycin/cisplatin/vincristine

    Newsletter Article 06 February 2013 Pages: 8 - 8